Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma

Background: Immune checkpoint inhibitor (ICI) therapy has been proved to be a promising therapy to many types of solid tumors. However, effective biomarker for estimating the response to ICI therapy and prognosis of hepatocellular carcinoma (HCC) patients remains underexplored. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yinfang, Zou, Ling, Liu, Xuejun, Luo, Judong, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593215/
https://www.ncbi.nlm.nih.gov/pubmed/34796177
http://dx.doi.org/10.3389/fcell.2021.760079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593215/
https://www.ncbi.nlm.nih.gov/pubmed/34796177
http://dx.doi.org/10.3389/fcell.2021.760079

Ejemplares similares